Conmed (CNMD) Revenue Growth (3y) (2013 - 2026)
Conmed (CNMD) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 0.73% |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn | 2.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.38% |
| Dec 31, 2025 | 14.16% |
| Sep 30, 2025 | 7.10% |
| Jun 30, 2025 | 7.29% |
| Mar 31, 2025 | 9.85% |
| Dec 31, 2024 | 8.09% |
| Sep 30, 2024 | 8.37% |
| Jun 30, 2024 | 9.18% |
| Mar 31, 2024 | 10.30% |
| Dec 31, 2023 | 8.96% |
| Sep 30, 2023 | 8.59% |
| Jun 30, 2023 | 26.27% |
| Mar 31, 2023 | 11.35% |
| Dec 31, 2022 | -1.79% |
| Sep 30, 2022 | 5.60% |
| Jun 30, 2022 | 5.17% |
| Mar 31, 2022 | 3.53% |
| Dec 31, 2021 | 4.16% |
| Sep 30, 2021 | 7.14% |
| Jun 30, 2021 | 6.23% |